Unichem Laboratories Limited (BOM: 506690)

Unichem Laboratories Balance Sheet

Financials in millions INR. Fiscal year is April - March.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2024	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020
Cash & Equivalents	1,980	1,509	1,838	1,092	774.61	2,315
Short-Term Investments	-	-	-	2,260	-	-
Trading Asset Securities	-	13.39	15.36	376.28	2,364	4,191
Cash & Short-Term Investments	1,980	1,523	1,853	3,728	3,139	6,506
Cash Growth	199.42%	-17.83%	-50.30%	18.76%	-51.76%	-34.79%
Accounts Receivable	6,304	6,104	5,886	4,954	2,503	3,901
Other Receivables	86.7	136.88	96.35	135.5	428.35	456.18
Receivables	6,391	6,241	5,983	5,090	2,931	4,358
Inventory	8,375	7,127	6,288	6,083	5,548	4,191
Prepaid Expenses	-	206.61	234.32	210.48	189.98	182.19
Other Current Assets	1,552	1,878	1,561	1,372	1,965	1,627
Total Current Assets	18,298	16,975	15,919	16,484	13,773	16,865
Property, Plant & Equipment	12,964	13,171	14,026	14,823	14,464	11,950
Long-Term Investments	61.1	0.2	1.61	2.85	1,556	1,308
Goodwill	15.5	15.45	15.45	15.45	15.45	15.45
Long-Term Deferred Tax Assets	-	67.75	101.13	43.55	139.54	29.38
Other Long-Term Assets	1,770	1,462	1,867	1,818	1,309	1,279
Total Assets	33,110	31,693	31,930	33,188	31,257	31,447
Accounts Payable	3,618	2,994	2,907	1,832	2,101	2,502
Accrued Expenses	-	2,047	699.37	555.94	523.02	507.17
Short-Term Debt	-	1,553	2,081	2,157	1,006	1,840
Current Portion of Long-Term Debt	2,428	256.63	256.63	256.63	-	-
Current Portion of Leases	58.8	42.12	51.6	42.18	41.58	40.21
Current Income Taxes Payable	-	22.07	4.91	20.95	32.61	6.31
Current Unearned Revenue	-	76.93	245.27	269.49	282.88	100.89
Other Current Liabilities	2,092	88.07	150.56	387.32	1,070	670.2
Total Current Liabilities	8,196	7,079	6,396	5,521	5,058	5,667
Long-Term Debt	254.8	382.22	636.49	890.11	-	-
Long-Term Leases	259.7	241.53	114.93	145.71	143.1	184.54
Long-Term Deferred Tax Liabilities	0.2	-	-	-	137.02	-
Other Long-Term Liabilities	392.4	280.49	294.95	317.72	290.11	255.39
Total Liabilities	9,103	8,069	7,577	7,004	5,689	6,134
Common Stock	140.8	140.81	140.81	140.81	140.81	140.81
Additional Paid-In Capital	-	13.3	13.3	13.3	13.3	13.3
Retained Earnings	-	23,391	23,975	25,061	25,012	24,950
Comprehensive Income & Other	23,866	79.31	223.87	969.19	402.42	209.21
Shareholders' Equity	24,007	23,624	24,353	26,184	25,568	25,314
Total Liabilities & Equity	33,110	31,693	31,930	33,188	31,257	31,447
Total Debt	3,001	2,475	3,140	3,492	1,191	2,065
Net Cash (Debt)	-1,021	-952.63	-1,288	236.25	1,948	4,441
Net Cash Growth	-	-	-	-87.87%	-56.14%	-44.36%
Net Cash Per Share	-14.51	-13.53	-18.29	3.35	27.67	63.08
Filing Date Shares Outstanding	70.25	70.41	70.41	70.41	70.41	70.41
Total Common Shares Outstanding	70.25	70.41	70.41	70.41	70.41	70.41
Working Capital	10,102	9,896	9,523	10,963	8,716	11,197
Book Value Per Share	341.71	335.54	345.90	371.90	363.16	359.54
Tangible Book Value	23,991	23,609	24,338	26,169	25,553	25,298
Tangible Book Value Per Share	341.49	335.32	345.68	371.68	362.94	359.32
Land	-	37.8	37.8	37.8	37.8	56.78
Buildings	-	5,108	5,101	3,872	3,417	3,259
Machinery	-	11,904	11,587	9,123	7,842	7,082
Construction In Progress	-	1,227	1,475	4,938	5,675	3,305

Source: S&P Capital IQ. Standard template. Financial Sources.